Literature DB >> 3888579

Butorphanol.

I J Pachter, R P Evens.   

Abstract

Butorphanol (Stadol) is a synthetic agonist-antagonist analgesic from the 14-hydroxymorphinan series. Animal studies display analgesia, antitussive effects, low gastrointestinal activity, limited respiratory depression, some cardiovascular and skeletal muscle actions, diuresis, slight miosis and opiate antagonism. Butorphanol is metabolized in the liver with renal excretion, yielding a half-life of 3-4 h. Pain relief is good to excellent with parenteral administration in 90% of patients with moderate to severe pain. Surgical anesthetic indications involve preoperative and preinduction supplementation, balanced anesthesia and postoperative pain. Side effects are sedation, nausea, elevated pulmonary vascular pressures and rarely CNS excitation. Limited respiratory depression exists. Butorphanol is a potent analgesic agent with a favorable side effect profile.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3888579     DOI: 10.1016/0376-8716(85)90065-1

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  6 in total

Review 1.  Role of active metabolites in the use of opioids.

Authors:  Janet K Coller; Lona L Christrup; Andrew A Somogyi
Journal:  Eur J Clin Pharmacol       Date:  2008-10-29       Impact factor: 2.953

2.  Evaluation of the mu and kappa opioid actions of butorphanol in humans through differential naltrexone blockade.

Authors:  S L Walsh; A E Chausmer; E C Strain; G E Bigelow
Journal:  Psychopharmacology (Berl)       Date:  2007-10-02       Impact factor: 4.530

3.  Molecular Interaction Between Butorphanol and κ-Opioid Receptor.

Authors:  Jiafu Ji; Wenzhen Lin; Amey Vrudhula; Jin Xi; Alexei Yeliseev; John R Grothusen; Weiming Bu; Renyu Liu
Journal:  Anesth Analg       Date:  2020-09       Impact factor: 6.627

4.  In Vitro and In Vivo Profile of PPL-101 and PPL-103: Mixed Opioid Partial Agonist Analgesics with Low Abuse Potential.

Authors:  Taline V Khroyan; Andrea Cippitelli; Nicholas Toll; John A Lawson; William Crossman; Willma E Polgar; Lawrence Toll
Journal:  Front Psychiatry       Date:  2017-04-12       Impact factor: 4.157

5.  The effects of fentanyl, oxycodone, and butorphanol on gastrointestinal function in patients undergoing laparoscopic hysterectomy: a prospective, double-blind, randomized controlled trial.

Authors:  Minna Guo; Shijiang Liu; Jian Gao; Chuanbao Han; Chun Yang; Cunming Liu
Journal:  BMC Anesthesiol       Date:  2022-02-24       Impact factor: 2.217

6.  Use of Butorphanol, Fentanyl, and Ketamine as Co-Induction Agents with Propofol for Laryngeal Mask Airway Insertion: A Comparative Study.

Authors:  Palanisamy Nagalakshmi; Sundararajan Leo; S Uthirapathi
Journal:  Anesth Essays Res       Date:  2018 Jul-Sep
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.